Information Provided By:
Fly News Breaks for February 15, 2017
CYNO, HOLX
Feb 15, 2017 | 09:04 EDT
As previously reported, Needham analyst Mike Matson upgraded Hologic (HOLX) to Buy from Hold, with a $46 price target, after the company announced it is acquiring Cynosure (CYNO) for $1.44B with an all-cash tender offer. While he acknowledges the deal surprised him, Matson says it makes sense for Hologic, noting that Cynosure should increase the company's revenue growth and EPS.
News For HOLX;CYNO From the Last 2 Days
There are no results for your query HOLX;CYNO